Ferulic Acid Combined With Bone Marrow Mesenchymal Stem Cells Attenuates the Activation of Hepatic Stellate Cells and Alleviates Liver Fibrosis
Bone marrow mesenchymal stem cells (BMSCs) can effectively alleviate liver fibrosis, but the efficacy of cell therapy alone is insufficient. In recent years, a combination of traditional Chinese medicine (TCM) and cell therapy has been increasingly used to treat diseases in clinical trials. Ferulic...
Main Authors: | Rui Zhang, Wenhang Li, Xiaodan Jiang, Xinyi Cui, Hongjie You, Zuoqing Tang, Wenlan Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.863797/full |
Similar Items
-
Naringenin alleviates liver fibrosis by triggering autophagy-dependent ferroptosis in hepatic stellate cells
by: Ting Yu, et al.
Published: (2024-04-01) -
Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway
by: Mu M, et al.
Published: (2018-12-01) -
Human placental mesenchymal stem cells ameliorate liver fibrosis in mice by upregulation of Caveolin1 in hepatic stellate cells
by: Yunqi Yao, et al.
Published: (2021-05-01) -
Noncoding RNAs Interactions in Hepatic Stellate Cells during Hepatic Fibrosis
by: Siti Aishah Sulaiman, et al.
Published: (2021-11-01) -
ZDHHC16 restrains osteogenic differentiation of bone marrow mesenchymal stem cells by inhibiting phosphorylation of CREB
by: Zhiwei Li, et al.
Published: (2023-01-01)